Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Chubb
Fuji
Queensland Health
Dow
Baxter
Healthtrust
Argus Health
Cerilliant

Generated: January 22, 2019

DrugPatentWatch Database Preview

Tentative Approvals for: Alembic Pharms Ltd

« Back to Dashboard

Alembic Pharms Ltd Drugs with Tentative Approvals

Applicant Generic Name NDA Strength Dosage Form
Alembic Pharms Ltd vilazodone hydrochloride 208202 20MG TABLET;ORAL
Alembic Pharms Ltd fesoterodine fumarate 204973 8MG TABLET, EXTENDED RELEASE;ORAL
Alembic Pharms Ltd pregabalin 203459 150MG CAPSULE;ORAL
Applicant Generic Name NDA Strength Dosage Form

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Farmers Insurance
Daiichi Sankyo
Federal Trade Commission
McKinsey
US Army
Julphar
Cipla
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.